This Amendment No. 1 (Amendment No. 1) amends and supplements the
Schedule 13G filed on July 20, 2020 (the Original Filing) by Boxer Capital, LLC (Boxer Capital), Boxer Asset Management Inc. (Boxer Management) and Joe Lewis (together with Boxer Capital and Boxer Management,
the Reporting Persons). The Original Filing remains in effect except to the extent that it is amended, restated or superseded by information contained in this Amendment No. 1. Capitalized terms used and not defined in this Amendment
No. 1 have the meanings set forth in the Original Filing, as amended.
Item 1(a).
|
Name of Issuer:
|
POINT Biopharma Global Inc. (the Issuer)
Item 1(b).
|
Address of Issuers Principal Executive Offices:
|
4850 West 78th Street
Indianapolis, IN 46268
Item 2(a).
|
Name of Person Filing:
|
This Schedule 13G is jointly filed by the Reporting Persons. Boxer Management is the managing member and majority owner of Boxer Capital. Joe
Lewis is the sole indirect beneficial owner of and controls Boxer Management.
Item 2(b).
|
Address of Principal Business Office, or, if none, Residence:
|
The principal business address of Boxer Capital is: 12860 El Camino Real, Suite 300, San Diego, CA 92130. The principal business address of
Boxer Management and Joe Lewis is: Cay House, EP Taylor Drive N7776, Lyford Cay, New Providence, Bahamas.
Boxer Capital is a limited liability company organized under the laws of Delaware. Boxer Management is a corporation organized under the laws
of the Bahamas. Joe Lewis is a citizen of the United Kingdom.
Item 2(d).
|
Title of Class of Securities:
|
Common stock, par value $0.0001 per share (the Common Stock)
88339T103
Item 3.
|
If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether the person filing is
a:
|
Not applicable.
(a) Amount beneficially owned:
The Reporting Persons beneficially own 2,500,000 shares of Common Stock.
(b) Percent of class:
The number
of shares of Common Stock beneficially owned by the Reporting Persons represent 2.8% of the Issuers outstanding Common Stock based on 90,121,794 shares of Common Stock outstanding as of November 8, 2021, as set forth in the Issuers
Quarterly Report on Form 10-Q filed with SEC on November 12, 2021.
(c) Number of shares as to
which such person has:
(i) Sole power to vote or to direct the vote:
None of the Reporting Persons has sole power to vote or to direct the vote of any shares of Common Stock.
(ii) Shared power to vote or to direct the vote:
The Reporting Persons have shared power to vote or to direct the vote of the 2,500,000 shares of Common Stock they beneficially own.
(iii) Sole power to dispose or to direct the disposition of:
None of the Reporting Persons has sole power to dispose or to direct the disposition of any shares of Common Stock.
(iv) Shared power to dispose or to direct the disposition of:
The Reporting Persons have shared power to dispose or to direct the disposition of the 2,500,000 shares of Common Stock they beneficially
own.
Item 5.
|
Ownership of Five Percent or Less of a Class.
|
With respect to each Reporting Person:
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of
more than 5 percent of the class of securities, check the following ☒.
(c) By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not
held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other
than activities solely in connection with a nomination under § 240.14a-11.